• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重组呼吸道合胞病毒F蛋白的表达受到低效核输出和mRNA加工的阻碍。

Recombinant respiratory syncytial virus F protein expression is hindered by inefficient nuclear export and mRNA processing.

作者信息

Huang Kelly, Lawlor Heather, Tang Roderick, MacGill Randall S, Ulbrandt Nancy D, Wu Herren

机构信息

MedImmune, One MedImmune Way, Gaithersburg, MD 20878, USA.

出版信息

Virus Genes. 2010 Apr;40(2):212-21. doi: 10.1007/s11262-010-0449-8. Epub 2010 Jan 29.

DOI:10.1007/s11262-010-0449-8
PMID:20111897
Abstract

Studies of the fusion activity of respiratory syncytial virus (RSV) F protein are significantly hindered by low recombinant expression levels. While infection produces F protein levels detectable by western blot, recombinant expression produces undetectable to low levels of F protein. Identifying the obstacles that hinder recombinant F protein expression may lead to improved expression and facilitate the study of F protein function. We hypothesized that nuclear localization and/or inefficient RNA polymerase II-mediated transcription contribute to poor recombinant F protein expression. This study shows a combination of stalled nuclear export, premature polyadenylation, and low mRNA abundance all contribute to low recombinant F protein expression levels. In addition, this study provides an expression optimization strategy that results in greater F protein expression levels than observed by codon-optimization of the F protein gene, which will be useful for future studies of F protein function.

摘要

呼吸道合胞病毒(RSV)F蛋白融合活性的研究因重组表达水平低而受到显著阻碍。虽然感染产生的F蛋白水平可通过蛋白质免疫印迹法检测到,但重组表达产生的F蛋白水平却检测不到或很低。识别阻碍重组F蛋白表达的障碍可能会提高表达水平并促进对F蛋白功能的研究。我们推测核定位和/或RNA聚合酶II介导的转录效率低下导致重组F蛋白表达不佳。本研究表明,停滞的核输出、过早的聚腺苷酸化和低mRNA丰度共同导致重组F蛋白表达水平低下。此外,本研究提供了一种表达优化策略,该策略所产生的F蛋白表达水平高于对F蛋白基因进行密码子优化所观察到的水平,这将有助于未来对F蛋白功能的研究。

相似文献

1
Recombinant respiratory syncytial virus F protein expression is hindered by inefficient nuclear export and mRNA processing.重组呼吸道合胞病毒F蛋白的表达受到低效核输出和mRNA加工的阻碍。
Virus Genes. 2010 Apr;40(2):212-21. doi: 10.1007/s11262-010-0449-8. Epub 2010 Jan 29.
2
Expression of RNA virus proteins by RNA polymerase II dependent expression plasmids is hindered at multiple steps.RNA 病毒蛋白通过依赖 RNA 聚合酶 II 的表达质粒进行表达在多个步骤中受到阻碍。
Virol J. 2007 Jun 5;4:51. doi: 10.1186/1743-422X-4-51.
3
A critical phenylalanine residue in the respiratory syncytial virus fusion protein cytoplasmic tail mediates assembly of internal viral proteins into viral filaments and particles.呼吸合胞病毒融合蛋白胞质尾端的一个关键苯丙氨酸残基介导内部病毒蛋白组装成病毒丝和颗粒。
mBio. 2012 Feb 7;3(1). doi: 10.1128/mBio.00270-11. Print 2012.
4
A Respiratory Syncytial Virus Attachment Gene Variant Associated with More Severe Disease in Infants Decreases Fusion Protein Expression, Which May Facilitate Immune Evasion.一种与婴儿更严重疾病相关的呼吸道合胞病毒附着基因变异体降低融合蛋白表达,这可能有助于免疫逃避。
J Virol. 2020 Dec 22;95(2). doi: 10.1128/JVI.01201-20.
5
Enhanced Neutralizing Antibody Response Induced by Respiratory Syncytial Virus Prefusion F Protein Expressed by a Vaccine Candidate.候选疫苗表达的呼吸道合胞病毒预融合F蛋白诱导的中和抗体反应增强
J Virol. 2015 Sep;89(18):9499-510. doi: 10.1128/JVI.01373-15. Epub 2015 Jul 8.
6
Improved Prefusion Stability, Optimized Codon Usage, and Augmented Virion Packaging Enhance the Immunogenicity of Respiratory Syncytial Virus Fusion Protein in a Vectored-Vaccine Candidate.改善的预融合稳定性、优化的密码子使用和增强的病毒体包装提高了呼吸道合胞病毒融合蛋白在一种候选载体疫苗中的免疫原性。
J Virol. 2017 Jul 12;91(15). doi: 10.1128/JVI.00189-17. Print 2017 Aug 1.
7
Immunogenicity and efficacy of codon optimized DNA vaccines encoding the F-protein of respiratory syncytial virus.编码呼吸道合胞病毒F蛋白的密码子优化DNA疫苗的免疫原性和效力
Vaccine. 2007 Oct 10;25(41):7271-9. doi: 10.1016/j.vaccine.2007.07.025. Epub 2007 Aug 23.
8
Secretion of the respiratory syncytial virus fusion protein from insect cells using the baculovirus expression system.利用杆状病毒表达系统从昆虫细胞中分泌呼吸道合胞病毒融合蛋白。
Methods Mol Biol. 2007;379:149-61. doi: 10.1007/978-1-59745-393-6_11.
9
Characterization of recombinant influenza A virus as a vector expressing respiratory syncytial virus fusion protein epitopes.重组甲型流感病毒作为表达呼吸道合胞病毒融合蛋白表位的载体的特性分析。
J Gen Virol. 2014 Sep;95(Pt 9):1886-1891. doi: 10.1099/vir.0.064105-0. Epub 2014 Jun 9.
10
Use of a novel cell-based fusion reporter assay to explore the host range of human respiratory syncytial virus F protein.使用一种新型的基于细胞的融合报告基因检测法来探究人呼吸道合胞病毒F蛋白的宿主范围。
Virol J. 2005 Jul 13;2:54. doi: 10.1186/1743-422X-2-54.

引用本文的文献

1
RSV F evolution escapes some monoclonal antibodies but does not strongly erode neutralization by human polyclonal sera.呼吸道合胞病毒F蛋白的进化能逃避一些单克隆抗体,但不会严重削弱人多克隆血清的中和作用。
J Virol. 2025 Jul 22;99(7):e0053125. doi: 10.1128/jvi.00531-25. Epub 2025 Jul 3.
2
mRNAdesigner: an integrated web server for optimizing mRNA design and protein translation in eukaryotes.mRNA设计器:用于优化真核生物中mRNA设计和蛋白质翻译的集成网络服务器。
Nucleic Acids Res. 2025 Jul 7;53(W1):W415-W426. doi: 10.1093/nar/gkaf410.
3
RSV F evolution escapes some monoclonal antibodies but does not strongly erode neutralization by human polyclonal sera.

本文引用的文献

1
Immunization by influenza virus-like particles protects aged mice against lethal influenza virus challenge.流感病毒样颗粒免疫可保护老年小鼠免受致死性流感病毒攻击。
Antiviral Res. 2009 Dec;84(3):215-24. doi: 10.1016/j.antiviral.2009.09.005. Epub 2009 Sep 20.
2
Rabies virus glycoprotein expression in Drosophila S2 cells. I: design of expression/selection vectors, subpopulations selection and influence of sodium butyrate and culture medium on protein expression.狂犬病病毒糖蛋白在果蝇S2细胞中的表达。I:表达/选择载体的设计、亚群选择以及丁酸钠和培养基对蛋白质表达的影响。
J Biotechnol. 2009 Aug 20;143(2):103-10. doi: 10.1016/j.jbiotec.2009.07.003. Epub 2009 Jul 15.
3
呼吸道合胞病毒融合蛋白(RSV F)的进化能逃避一些单克隆抗体,但不会严重削弱人多克隆血清的中和作用。
bioRxiv. 2025 Mar 11:2025.03.11.642476. doi: 10.1101/2025.03.11.642476.
4
Reverse genetics systems for contemporary isolates of respiratory syncytial virus enable rapid evaluation of antibody escape mutants.用于呼吸道合胞病毒当代分离株的反向遗传学系统可快速评估抗体逃逸突变体。
Proc Natl Acad Sci U S A. 2021 Apr 6;118(14). doi: 10.1073/pnas.2026558118.
5
RSV Vaccine Based on Rhabdoviral Vector Protects after Single Immunization.基于弹状病毒载体的呼吸道合胞病毒疫苗单次免疫后具有保护作用。
Vaccines (Basel). 2019 Jul 3;7(3):59. doi: 10.3390/vaccines7030059.
6
A novel respiratory syncytial virus (RSV) F subunit vaccine adjuvanted with GLA-SE elicits robust protective TH1-type humoral and cellular immunity in rodent models.一种新型的呼吸道合胞病毒(RSV)F亚基疫苗,佐以GLA-SE,在啮齿动物模型中引发了强大的保护性TH1型体液免疫和细胞免疫。
PLoS One. 2015 Mar 20;10(3):e0119509. doi: 10.1371/journal.pone.0119509. eCollection 2015.
7
Novel vaccine regimen elicits strong airway immune responses and control of respiratory syncytial virus in nonhuman primates.新型疫苗方案可引发非人类灵长类动物强烈的气道免疫应答和呼吸道合胞病毒控制。
J Virol. 2014 Apr;88(8):3997-4007. doi: 10.1128/JVI.02736-13. Epub 2014 Jan 22.
8
RAGE inhibits human respiratory syncytial virus syncytium formation by interfering with F-protein function.RAGE 通过干扰 F 蛋白功能抑制人呼吸道合胞病毒合胞体的形成。
J Gen Virol. 2013 Aug;94(Pt 8):1691-1700. doi: 10.1099/vir.0.049254-0. Epub 2013 Apr 4.
9
A stabilized respiratory syncytial virus reverse genetics system amenable to recombination-mediated mutagenesis.一种稳定的呼吸道合胞病毒反向遗传学系统,适用于重组介导的诱变。
Virology. 2012 Dec 5;434(1):129-36. doi: 10.1016/j.virol.2012.09.022. Epub 2012 Oct 11.
10
Targeting RSV with vaccines and small molecule drugs.利用疫苗和小分子药物针对呼吸道合胞病毒(RSV)
Infect Disord Drug Targets. 2012 Apr;12(2):110-28. doi: 10.2174/187152612800100143.
Sendai virus recombinant vaccine expressing hPIV-3 HN or F elicits protective immunity and combines with a second recombinant to prevent hPIV-1, hPIV-3 and RSV infections.
表达人副流感病毒3型血凝素神经氨酸酶(HN)或融合蛋白(F)的仙台病毒重组疫苗可引发保护性免疫,并与第二种重组疫苗联合使用以预防人副流感病毒1型、人副流感病毒3型和呼吸道合胞病毒感染。
Vaccine. 2008 Jun 25;26(27-28):3480-8. doi: 10.1016/j.vaccine.2008.04.022. Epub 2008 May 1.
4
Prevention of hospitalization due to respiratory syncytial virus: results from the Palivizumab Outcomes Registry.呼吸道合胞病毒所致住院的预防:帕利珠单抗疗效登记研究结果
J Perinatol. 2008 Jul;28(7):511-7. doi: 10.1038/jp.2008.28. Epub 2008 Mar 27.
5
The fusion protein of respiratory syncytial virus triggers p53-dependent apoptosis.呼吸道合胞病毒的融合蛋白触发p53依赖性细胞凋亡。
J Virol. 2008 Apr;82(7):3236-49. doi: 10.1128/JVI.01887-07. Epub 2008 Jan 23.
6
Differential role of gamma interferon in inhibiting pulmonary eosinophilia and exacerbating systemic disease in fusion protein-immunized mice undergoing challenge infection with respiratory syncytial virus.γ干扰素在抑制呼吸道合胞病毒激发感染的融合蛋白免疫小鼠肺部嗜酸性粒细胞增多及加重全身疾病中的差异作用
J Virol. 2008 Mar;82(5):2196-207. doi: 10.1128/JVI.01949-07. Epub 2007 Dec 19.
7
Herpesvirus saimiri ORF57: a post-transcriptional regulatory protein.猴疱疹病毒ORF57:一种转录后调节蛋白。
Front Biosci. 2008 Jan 1;13:2928-38. doi: 10.2741/2898.
8
Recombinant Sendai virus induces T cell immunity against respiratory syncytial virus that is protective in the absence of antibodies.重组仙台病毒可诱导针对呼吸道合胞病毒的T细胞免疫,在无抗体的情况下具有保护作用。
Cell Immunol. 2007 Jun;247(2):85-94. doi: 10.1016/j.cellimm.2007.07.005. Epub 2007 Sep 29.
9
Immunogenicity and efficacy of recombinant RSV-F vaccine in a mouse model.重组呼吸道合胞病毒F疫苗在小鼠模型中的免疫原性和疗效
Vaccine. 2007 Aug 14;25(33):6211-23. doi: 10.1016/j.vaccine.2007.05.068. Epub 2007 Jun 26.
10
Expression of RNA virus proteins by RNA polymerase II dependent expression plasmids is hindered at multiple steps.RNA 病毒蛋白通过依赖 RNA 聚合酶 II 的表达质粒进行表达在多个步骤中受到阻碍。
Virol J. 2007 Jun 5;4:51. doi: 10.1186/1743-422X-4-51.